Patents Examined by Pierre Paul Eleniste
  • Patent number: 12233132
    Abstract: POZ-lipid conjugates and lipid nanoparticles (LNPs) including POZ-lipid conjugates used to facilitate delivery of an encapsulated payload. LNPs including POZ-lipid conjugates and a nucleic acid payload such as, but not limited to, mRNA or modified mRNA are disclosed. Such LNPs have no immunogenicity or reduced immunogenicity as compared to a corresponding LNP containing a PEG-lipid.
    Type: Grant
    Filed: February 4, 2022
    Date of Patent: February 25, 2025
    Assignee: Serina Therapeutics, Inc.
    Inventors: J Milton Harris, Michael Bentley, Tacey Viegas, Randall Moreadith, Robert J Sharpe, Kunsang Yoon, Zhihao Fang, Rebecca Weimer
  • Patent number: 12221413
    Abstract: The present invention provides a scalable synthesis of enantiomerically pure brivaracetam, and related derivatives.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: February 11, 2025
    Assignee: SUZHOU PENGXU PHARMATECH CO. LTD.
    Inventors: Peng Wang, Pixu Li, Qiang Wei, Yuanhua Liu
  • Patent number: 12121507
    Abstract: A method for preparing a water-soluble curcumin liquid includes the following steps: A) dissolving curcumin, vitamin C and ascorbyl palmitate in an ethanol aqueous solution, evaporating ethanol under reduced pressure, and vacuum drying to obtain a curcumin-vitamin C-ascorbyl palmitate co-crystal; and B) high-speed emulsifying the curcumin-vitamin C-ascorbyl palmitate co-crystal and a water-soluble colloidal solution that includes an emulsifying additive under vacuum, sequentially conducting a two-stage wet grinding, a homogenization and a potential adjustment to obtain the water-soluble curcumin liquid.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: October 22, 2024
    Assignee: HENAN ZHONGDA HENGYUAN BIOTECHNOLOGY STOCK CO., LTD.
    Inventors: Honglong Li, Xiaosong Xu, Ziheng Jin, Linzheng Li, Congying Shi, Yulian Guo, Chunfeng Yu, Yaqiong Zhang